Pacira BioSciences, Inc. PCRX Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s other intangible assets—net?
- Pacira BioSciences, Inc. (PCRX) reported other intangible assets—net of $353.23M in Q1 2026.
- How has Pacira BioSciences, Inc.'s other intangible assets—net changed year-over-year?
- Pacira BioSciences, Inc.'s other intangible assets—net decreased by 18.8% year-over-year, from $434.97M to $353.23M.
- What is the long-term trend for Pacira BioSciences, Inc.'s other intangible assets—net?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s other intangible assets—net has grown at a 30.7% compound annual growth rate (CAGR), from $96.52M to $368.1M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.